JILL SMOTHERS: Open Payments
NPI 1912104183 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 19 payments from 4 companies in 2025. Trend: 2023 $465 · 2024 $490 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $211 |
| GENZYME CORPORATION | 2 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
Products named: XIFAXAN, DUPIXENT, FARXIGA, Rhapsido.
Industry payments across CO — which companies pay providers there.
